Ozempic and Wegovy linked to drop in violent behavior, study finds
2 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
Velocity
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
The brief
"Ozempic and Wegovy linked to drop in violent behavior, study finds" is generating significant coverage in the Health category, with 2 articles from 2 distinct sources tracked by PULSE so far.
Outlets currently covering the story include CBS News and Healthline. PULSE measures a story's velocity from how quickly new articles appear and how many independent newsrooms join the coverage.
This brief was generated by PULSE's extractive engine from coverage metadata only. The latest headlines from every source are listed below; the velocity chart shows how the story is developing in real time.
Generated by PULSE's extractive engine from coverage metadata only — no AI-written claims. Updated 51d ago.
Quick answers
Why is "Ozempic and Wegovy linked to drop in violent behavior, study finds" trending?
Because 2 independent news sources published 2 articles about it in a short window — a coverage burst PULSE classifies as a trend.
How does PULSE measure this trend?
PULSE scores velocity from the rate of new articles weighted by source diversity, snapshotted hourly. The full method is public on our methodology page.
Is this trend still active?
The status badge on this page updates hourly: rising, peaking, cooling, or archived once coverage stops for 48 hours.
Coverage (2)
- Rutgers University study connects GLP-1 medications, lower risk of violent behavior CBS News · 93d ago
- Ozempic, Wegovy Linked to Reduced Violent Behavior, Impulsivity Healthline · 93d ago
Topics
Related trends
Use of GLP-1s Like Ozempic Is Forcing Food Companies to Adapt
2 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
Novo Nordisk (NVO) and Eli Lilly (LLY)’s Weight-Loss Drugs Still Work at Smaller Doses, Study Finds
Recent studies indicate that popular weight-loss medications manufactured by Novo Nordisk and Eli Lilly remain effective at smaller doses.
Large genetic study links GLP-1 receptor activation to improved mental well-being
A large genetic study connects GLP-1 receptor activation to improved mental well-being.
Will Wegovy Be A Part D, A Medicare GLP-1 Bridge Drug Or Neither?
1 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
From ‘Ozempic breath’ to hair loss: sorting the science from the hype about weight loss jabs
7 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
The weight I lost with GLP-1s came back ‘with taxes’
Recent coverage examines rapid weight regain after discontinuing GLP-1 medications like Ozempic, semaglutide, and tirzepatide.